Location History:
- Lidingö, SE (2003)
- Lidingo, SE (1995 - 2006)
Company Filing History:
2 out of 47 
1 out of 60 
1 out of 5 
Years Active: 1995-2006
Title: The Innovative Mind of Erik Holmgren
Introduction
Erik Holmgren, an accomplished inventor based in Lidingo, Sweden, has made significant contributions to the field of biotechnology. With six patents to his name, Holmgren has focused on the development of matrix metalloproteinases, which play a crucial role in various biological processes.
Latest Patents
Holmgren's latest patents revolve around matrix metalloproteinases (MMPs). His inventions provide genes encoding novel matrix metalloproteinases, constructs and recombinant host cells that incorporate the genes, as well as the MMP polypeptides encoded by these genes. Additionally, his patents include antibodies to the MMP polypeptides and methods for making and utilizing all of the aforementioned components. These innovations highlight his commitment to advancing our understanding of MMPs and their applications in medicine.
Career Highlights
Throughout his career, Erik Holmgren has been associated with notable companies such as Pharmacia & Upjohn Aktiebolag and Esperion Therapeutics, Inc. His work at these organizations has contributed to his expertise in the field and has facilitated the development of his groundbreaking patents.
Collaborations
Holmgren has collaborated with esteemed colleagues, including Mats Lake and Cesare Sirtori. These collaborations have enriched his research and innovation efforts, allowing for a mutual exchange of ideas and expertise in the realm of biotechnology.
Conclusion
Erik Holmgren's impact on the field of biotechnology through his innovative inventions and collaborations cannot be overstated. His work on matrix metalloproteinases demonstrates his dedication to advancing scientific knowledge and improving medical applications. As he continues to develop new ideas and technologies, Holmgren undoubtedly remains a valued contributor to the scientific community.